Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6 | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6

He T, Lopez-Olivo MA, Hur C, Chhatwal J. Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6. Aliment Pharmacol Ther. 2017;46(8):711-721.

Publication Type:

Journal Article

Authors:

He, T.; Lopez-Olivo, MA; Hur, C; Chhatwal, J.

Source:

Aliment Pharmacol Ther, Volume 46, Issue 8, p.711-721 (2017)

Cited On:

Overview of Cost, Reimbursement, and Cost-Effectiveness Considerations for Hepatitis C Treatment Regimens

Export Citation:

RIS Format

Top